CCL8 and hepatocellular carcinoma: Furthermore, it has been reported recently that CAXIIis can interfere with the metabolism of macrophages by regulating CCL8 and PERK expression (46) and promote the therapeutic effect of PD-1 inhibitors in HCC treatment (47).